Literature DB >> 22371504

Structural basis for dual nucleotide selectivity of aminoglycoside 2''-phosphotransferase IVa provides insight on determinants of nucleotide specificity of aminoglycoside kinases.

Kun Shi1, Albert M Berghuis.   

Abstract

Enzymatic phosphorylation through a family of enzymes called aminoglycoside O-phosphotransferases (APHs) is a major mechanism by which bacteria confer resistance to aminoglycoside antibiotics. Members of the APH(2″) subfamily are of particular clinical interest because of their prevalence in pathogenic strains and their broad substrate spectra. APH(2″) enzymes display differential preferences between ATP or GTP as the phosphate donor, with aminoglycoside 2″-phosphotransferase IVa (APH(2″)-IVa) being a member that utilizes both nucleotides at comparable efficiencies. We report here four crystal structures of APH(2″)-IVa, two of the wild type enzyme and two of single amino acid mutants, each in complex with either adenosine or guanosine. Together, these structures afford a detailed look at the nucleoside-binding site architecture for this enzyme and reveal key elements that confer dual nucleotide specificity, including a solvent network in the interior of the nucleoside-binding pocket and the conformation of an interdomain linker loop. Steady state kinetic studies, as well as sequence and structural comparisons with members of the APH(2″) subfamily and other aminoglycoside kinases, rationalize the different substrate preferences for these enzymes. Finally, despite poor overall sequence similarity and structural homology, analysis of the nucleoside-binding pocket of APH(2″)-IVa shows a striking resemblance to that of eukaryotic casein kinase 2 (CK2), which also exhibits dual nucleotide specificity. These results, in complement with the multitude of existing inhibitors against CK2, can serve as a structural basis for the design of nucleotide-competitive inhibitors against clinically relevant APH enzymes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22371504      PMCID: PMC3339986          DOI: 10.1074/jbc.M112.349670

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  GTP plus water mimic ATP in the active site of protein kinase CK2.

Authors:  K Niefind; M Pütter; B Guerra; O G Issinger; D Schomburg
Journal:  Nat Struct Biol       Date:  1999-12

2.  Structural analyses of nucleotide binding to an aminoglycoside phosphotransferase.

Authors:  D L Burk; W C Hon; A K Leung; A M Berghuis
Journal:  Biochemistry       Date:  2001-07-31       Impact factor: 3.162

3.  The crystal structure of aminoglycoside-3'-phosphotransferase-IIa, an enzyme responsible for antibiotic resistance.

Authors:  Didier Nurizzo; Steven C Shewry; Michael H Perlin; Scott A Brown; Jaydev N Dholakia; Roy L Fuchs; Taru Deva; Edward N Baker; Clyde A Smith
Journal:  J Mol Biol       Date:  2003-03-21       Impact factor: 5.469

Review 4.  Aminoglycoside antibiotic resistance by enzymatic deactivation.

Authors:  Clyde A Smith; Edward N Baker
Journal:  Curr Drug Targets Infect Disord       Date:  2002-06

5.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

6.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

7.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

Review 8.  Aminoglycoside resistance in enterococci.

Authors:  J W Chow
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

9.  The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2.

Authors:  R Battistutta; S Sarno; E De Moliner; E Papinutto; G Zanotti; L A Pinna
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

Review 10.  Protein kinase inhibitors and antibiotic resistance.

Authors:  David L Burk; Albert M Berghuis
Journal:  Pharmacol Ther       Date:  2002 Feb-Mar       Impact factor: 12.310

View more
  14 in total

1.  Bulky "gatekeeper" residue changes the cosubstrate specificity of aminoglycoside 2''-phosphotransferase IIa.

Authors:  Monolekha Bhattacharya; Marta Toth; Clyde A Smith; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

2.  Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance.

Authors:  Peter J Stogios; Peter Spanogiannopoulos; Elena Evdokimova; Olga Egorova; Tushar Shakya; Nick Todorovic; Alfredo Capretta; Gerard D Wright; Alexei Savchenko
Journal:  Biochem J       Date:  2013-09-01       Impact factor: 3.857

3.  New trends in aminoglycosides use.

Authors:  Marina Y Fosso; Yijia Li; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

4.  The Biosynthesis of Capuramycin-type Antibiotics: IDENTIFICATION OF THE A-102395 BIOSYNTHETIC GENE CLUSTER, MECHANISM OF SELF-RESISTANCE, AND FORMATION OF URIDINE-5'-CARBOXAMIDE.

Authors:  Wenlong Cai; Anwesha Goswami; Zhaoyong Yang; Xiaodong Liu; Keith D Green; Sandra Barnard-Britson; Satoshi Baba; Masanori Funabashi; Koichi Nonaka; Manjula Sunkara; Andrew J Morris; Anatol P Spork; Christian Ducho; Sylvie Garneau-Tsodikova; Jon S Thorson; Steven G Van Lanen
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

5.  Antibiotic resistance and inhibition mechanism of novel aminoglycoside phosphotransferase APH(5) from B. subtilis subsp. subtilis strain RK.

Authors:  Rishikesh S Parulekar; Sagar S Barale; Kailas D Sonawane
Journal:  Braz J Microbiol       Date:  2019-08-10       Impact factor: 2.476

6.  Nucleoside triphosphate cosubstrates control the substrate profile and efficiency of aminoglycoside 3'-O-phosphotransferase type IIa.

Authors:  Selina Y L Holbrook; Matthew S Gentry; Oleg V Tsodikov; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2018-07-16       Impact factor: 3.597

Review 7.  Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections.

Authors:  Kristin J Labby; Sylvie Garneau-Tsodikova
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

8.  Induction and translocation of tissue transglutaminase isoforms increased phosphorylation in retinoic acid treated erythroleukemia cells.

Authors:  Bassam M Fraij
Journal:  Protein J       Date:  2013-08       Impact factor: 2.371

9.  Structure of the phosphotransferase domain of the bifunctional aminoglycoside-resistance enzyme AAC(6')-Ie-APH(2'')-Ia.

Authors:  Clyde A Smith; Marta Toth; Monolekha Bhattacharya; Hilary Frase; Sergei B Vakulenko
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-05-23

10.  Structural basis for the diversity of the mechanism of nucleotide hydrolysis by the aminoglycoside-2''-phosphotransferases.

Authors:  Clyde A Smith; Marta Toth; Nichole K Stewart; Lauren Maltz; Sergei B Vakulenko
Journal:  Acta Crystallogr D Struct Biol       Date:  2019-11-29       Impact factor: 7.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.